Hepatitis: all 3,372 studies
Page 27 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver FailureCompletedNCT01254994Phase 2
- VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and RaltegravirCompletedNCT01253551Phase 1
- Immunogenicity and Interchangeability of Two Inactivated Hepatitis A VaccinesCompletedNCT01252680Phase 4
- A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis CTerminatedNCT01250743Not applicable
- A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1CompletedNCT01247194Phase 1
- Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic HepatitisCompletedNCT01245257
- Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BStatus unknownNCT01243281Not applicable
- Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownNCT01242787Phase 2
- TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and RaltegravirCompletedNCT01241773Phase 1
- Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253CompletedNCT01237496Phase 3
- Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infectionCompletedNCT01231685Phase 2
- Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1CompletedNCT01226771Phase 3
- A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01225380Phase 2
- TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese VolunteersCompletedNCT01224197Phase 1
- A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01220947Phase 2
- Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.Status unknownNCT01220596Phase 3
- A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B InfectionTerminatedNCT01217632Phase 2
- Double-blind Randomized Controlled Trial in Severe Alcoholic HepatitisCompletedNCT01214226Phase 3
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundCompletedNCT01208311
- TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and TenofovirCompletedNCT01205139Phase 1
- Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath TestWithdrawnNCT01204827Phase 2/3
- Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e AntigenCompletedNCT01204762Phase 2
- TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected PatientsCompletedNCT01202825Phase 1
- Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C SubjectsCompletedNCT01200420Phase 2
- An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)CompletedNCT01200225
- Study of the Impact of Nitazoxanide on Chronic Hepatitis PatientsCompletedNCT01197157Phase 2/3
- Immune Dysregulation in Hepatitis C Patients With or Without ArthritisStatus unknownNCT01195987
- Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on HemodialysisCompletedNCT01195246Phase 3
- Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.CompletedNCT01195181Phase 4
- A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CCompletedNCT01194037Phase 1/2
- A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01193478Phase 1
- Ph IIA Study (SOC +/- NS5B)CompletedNCT01193361Phase 2
- An Study of Efficacy and Safety of ClevudineCompletedNCT01192854Phase 3
- A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis BStatus unknownNCT01189656Phase 2
- A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1CompletedNCT01185860Phase 1
- Duration of Long-term Immunity After Hepatitis B Virus ImmunizationCompletedNCT01182311
- A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1CompletedNCT01181024Phase 1
- A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.WithdrawnNCT01179594Phase 4
- Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.CompletedNCT01178996Phase 3
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis BStatus unknownNCT01172392Phase 3
- Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune HepatitisCompletedNCT01170351Phase 3
- Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected AdultsCompletedNCT01165359Phase 1
- A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.Status unknownNCT01164384Phase 1
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- Analysis of Trends Over Time of Hepatitis Related Incidence in PanamaCompletedNCT01159951
- Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian ChildrenCompletedNCT01159925
- Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?CompletedNCT01159613
- Study the Relationship Between Obesity and Hepatitis C ReplicationWithdrawnNCT01157975Phase 2
- A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)CompletedNCT01157104Phase 1
- Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)CompletedNCT01155427
- Romiplostim in Treating Hepatitis C-Infected Patients With ThrombocytopeniaTerminatedNCT01153919Phase 2
- Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Status unknownNCT01151397Not applicable
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?Status unknownNCT01146626Not applicable
- Study of VX-985 in Subjects With Chronic Hepatitis CCompletedNCT01144936Phase 1
- Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01143662Phase 2
- Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV PreventionStatus unknownNCT01142882Not applicable
- A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype IWithdrawnNCT01142700Phase 2
- Cholestatic Drug-induced Liver InjuryStatus unknownNCT01141322Phase 4
- Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis CCompletedNCT01140997Phase 2
- Prophylaxis of Hepatitis B Virus Recurrence After Liver TransplantationStatus unknownNCT01139203Not applicable
- Pegaferon and Ribavirin for Hepatitis CCompletedNCT01137383Phase 3
- TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose AdministrationCompletedNCT01134718Phase 1
- Lamivudine(LAM) Good Responder StudyCompletedNCT01128686
- Combination Hepatitis A and B Vaccine to Induce Immunity in Non-respondersWithdrawnNCT01126853Phase 4
- Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBVCompletedNCT01125696Phase 2
- TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun LightCompletedNCT01124799Phase 1
- Brief Intervention for Drug Misuse in the Emergency DepartmentCompletedNCT01124591Phase 2
- A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CCompletedNCT01121731Phase 1/2
- Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)CompletedNCT01121705Phase 3
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid PharmacotherapyCompletedNCT01120795Phase 4
- Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCVCompletedNCT01113814Not applicable
- Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01107483
- Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug UsersStatus unknownNCT01105611Phase 4
- Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineCompletedNCT01105559
- Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
- Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A InfectionCompletedNCT01102296Not applicable
- Chronic Hepatitis C (CHC) - Genotype 3 Infection in CanadaTerminatedNCT01100749
- EXtended Therapy in Hepatitis C Genotype 3 Infected PatientsTerminatedNCT01095445Phase 3
- Study of a Novel Therapeutic Vaccine for Hepatitis C VirusCompletedNCT01094873Phase 1
- A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV InfectionCompletedNCT01091077Phase 1
- TMC435-TiDP16-C112 - Interaction Trial With AntidepressantsCompletedNCT01090700Phase 1
- Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral TherapyStatus unknownNCT01090531
- Host Responses in Kidney-transplant Recipients With Chronic Hepatitis E Virus InfectionCompletedNCT01090232Not applicable
- A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.CompletedNCT01088659Phase 3
- Efficacy Optimizing Research of Lamivudine TherapyCompletedNCT01088009Phase 4
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedNCT01086085Phase 4
- The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) InfectionStatus unknownNCT01083251Not applicable
- Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)CompletedNCT01081158Phase 1
- A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionTerminatedNCT01080222Phase 2
- Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver FailureCompletedNCT01074645Phase 4
- A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After TransplantationCompletedNCT01074203Phase 1
- Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01072695Phase 2
- A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)CompletedNCT01070407Phase 1
- Health Promotion and Management for Hepatitis B CarriersStatus unknownNCT01065363Not applicable
- Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsWithdrawnNCT01062659
- Role of Cytokines in Hepatitis E Virus Infection During PregnancyCompletedNCT01062321
- A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard TherapyCompletedNCT01058512Phase 2